Metabolic Usage and Glycan Destinations of GlcNAz in E. coli
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.3c00501 ↗At a glance
Journal article in ACS Chemical Biology, 2024. Written by Alexander Eddenden and 6 co-authors. Institution: Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada. Major MEDLINE topics: Escherichia coli, Lipopolysaccharides. Cited 6 times so far (Crossref); 63 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, Canadian Institutes of Health Research, University of Toronto.
Abstract (original language)
Bacteria use a diverse range of carbohydrates to generate a profusion of glycans, with amino sugars, such as N-acetylglucosamine (GlcNAc), being prevalent in the cell wall and in many exopolysaccharides. The primary substrate for GlcNAc-containing glycans, UDP-GlcNAc, is the product of the bacterial hexosamine pathway and a key target for bacterial metabolic glycan engineering. Using the strategy of expressing NahK, to circumvent the hexosamine pathway, it is possible to directly feed the analogue of GlcNAc, N-azidoacetylglucosamine (GlcNAz), for metabolic labeling in Escherichia coli. The cytosolic production of UDP-GlcNAz was confirmed by using fluorescence-assisted polyacrylamide gel electrophoresis. The key question of where GlcNAz is incorporated was interrogated by analyzing potential sites including peptidoglycan (PGN), the biofilm-related exopolysaccharide poly-β-1,6-N-acetylglucosamine (PNAG), lipopolysaccharide (LPS), and the enterobacterial common antigen (ECA). The highest levels of incorporation were observed in PGN with lower levels in PNAG and no observable incorporation in LPS or ECA. The promiscuity of the PNAG synthase (PgaCD) toward UDP-GlcNAz in vitro and the lack of undecaprenyl-pyrophosphoryl-GlcNAz intermediates generated in vivo confirmed the incorporation preferences. The results of this work will guide the future development of carbohydrate-based probes and metabolic engineering strategies.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada.
- Department of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223-0001, United States.
- Program in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 0A4, Canada.
- Department of Biochemistry, University of Toronto, Toronto, Ontario M5G 0A4, Canada.
ORCID profiles: Alexander Eddenden, Jerry M Troutman, Mark Nitz
Funding
- NIGMS NIH HHS
- Canadian Institutes of Health Research
- University of Toronto
- Sick Kids Foundation
- Natural Sciences and Engineering Research Council of Canada
- National Institute of General Medical Sciences
Cite
APA
Eddenden, A., Dooda, M. K., Morrison, Z. A., Shankara Subramanian, A., Howell, P. L., Troutman, J. M., & Nitz, M. (2024). Metabolic Usage and Glycan Destinations of GlcNAz in E. coli. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00501
Vancouver
Eddenden A, Dooda MK, Morrison ZA, Shankara Subramanian A, Howell PL, Troutman JM, et al. Metabolic Usage and Glycan Destinations of GlcNAz in E. coli. ACS Chemical Biology. 2024. doi:10.1021/acschembio.3c00501
BibTeX
@article{Eddenden2024,
author = {Eddenden, Alexander and Dooda, Manoj K and Morrison, Zachary A and Shankara Subramanian, Adithya and Howell, P Lynne and Troutman, Jerry M and Nitz, Mark},
title = {Metabolic Usage and Glycan Destinations of GlcNAz in E. coli},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.3c00501}
}
EUVIMED